Agency Forms Undergoing Paperwork Reduction Act Review, 70354-70355 [E8-27618]
Download as PDF
70354
Federal Register / Vol. 73, No. 225 / Thursday, November 20, 2008 / Notices
William Blumenthal,
General Counsel.
[FR Doc. E8–27534 Filed 11–19–08: 8:45 am]
BILLING CODE 6750–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–0263]
Agency Information Collection
Request; 30-Day Public Comment
Request
Office of the Secretary.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services, is
publishing the following summary of a
proposed information collection request
for public comment. Interested persons
are invited to send comments regarding
this burden estimate or any other aspect
of this collection of information,
including any of the following subjects:
(1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
AGENCY:
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, e-mail your request,
including your address, phone number,
OMB number, and OS document
identifier, to
Sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–5683.
Written comments and
recommendations for the proposed
information collections must be directed
to the OS Paperwork Clearance Officer
at the above e-mail address within 30
days.
Proposed Project: Protection of
Human Subjects: Assurance
Identification/IRB Certification/
Declaration of Exemption Form
Extension—OMB No. 0990–0263—
Office for Human Research Protections.
Abstract: The Federal Policy for the
Protection of Human Subjects, known as
the Common Rule, requires that before
engaging in non-exempt human subjects
research that is conducted or supported
by a Common Rule department or
agency, each institution must: (1) Hold
an applicable assurance of compliance
[Section 103(a)]; and (2) certify to the
awarding department or agency that the
application or proposal for research has
been reviewed and approved by an IRB
designated in the assurance [Sections
103(b) and (f)]. The Office for Human
Research Protections is requesting a
three-year extension of the Protection of
Human Subjects: Assurance
Identification/IRB Certification/
Declaration of Exemption Form. That
form is designed to promote uniformity
among departments and agencies, and to
help ensure common means of
ascertaining institutional review board
certifications and other reporting
requirements relating to the protection
of human subjects in research.
Respondents are institutions engaged in
research involving human subjects
where the research is supported by
HHS. Institutional use of the form is
also relied upon by other federal
departments and agencies that have
codified or follow the Federal Policy for
the Protection of Human Subjects
(Common Rule). There are an estimated
total of 70,000 health or human research
studies supported each year, meaning
an average of 7 certifications per
institution annually, requiring an
estimated one-half hour per certification
for a total burden of 35,000 hours. Data
is collected as needed.
ESTIMATED ANNUALIZED BURDEN IN HOURS FOR IRB CERTIFICATION BURDEN
Number of
respondents
Form name
Number of
responses
per
respondent
Average
burden per
response
(in hours)
10,000
7
0.5
Protection of Human Subjects: Assurance Identification/IRB Certification/Declaration
of Exemption ................................................................................................................
John Teeter,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. E8–27628 Filed 11–19–08; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Centers for Disease Control and
Prevention
[30Day–08–0010]
rwilkins on PROD1PC63 with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
VerDate Aug<31>2005
18:26 Nov 19, 2008
Jkt 217001
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
The National Birth Defects Prevention
Study (NBDPS)—Revision—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Address the following criteria
provided in 5 CFR 1320.5(a): CDC has
been monitoring the occurrence of
serious birth defects and genetic
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Total
burden
hours
35,000
diseases in Atlanta since 1967 through
the Metropolitan Atlanta Congenital
Defects Program (MACDP). The MACDP
is a population-based surveillance
system for birth defects in the 5 counties
of Metropolitan Atlanta, which is being
requested for OMB clearance for three
additional years. Its primary purpose is
to describe the spatial and temporal
patterns of birth defects occurrence and
serves as an early warning system for
new Teratogens. In 1997, the Birth
Defects Risk Factor Surveillance
(BDRFS) study, a case-control study of
risk factors for selected birth defects,
became the National Birth Defects
Prevention Study (NBDPS). The major
components of the study did not
change.
The NBDPS is a case-control study of
major birth defects that includes cases
identified from existing birth defect
surveillance registries in nine states,
E:\FR\FM\20NON1.SGM
20NON1
70355
Federal Register / Vol. 73, No. 225 / Thursday, November 20, 2008 / Notices
including metropolitan Atlanta. Control
infants are randomly selected from birth
certificates or birth hospital records.
Mothers of case and control infants are
interviewed using a computer-assisted
telephone interview. The interview is
estimated to take one hour. A maximum
of thirty-six hundred interviews are
planned, 2,700 cases and 900 controls,
resulting in a maximum interview
burden of 3,600 hours for all Centers.
Parents are also asked to collect cheek
cells from themselves and their infants
for DNA testing. The collection of cheek
cells by the mother, father, and infant is
estimated to take about 10 minutes per
person. Each person will be asked to rub
1 brush inside the left cheek and 1
brush inside the right cheek for a total
of 2 brushes per person. Collection of
the cheek cells takes approximately 1–
2 minutes, but the estimate of burden is
10 minutes to account for reading and
understanding the consent form and
specimen collection instructions and
mailing back the completed kits. The
anticipated maximum burden for
collection of the cheek cells is 1,800
hours.
Information gathered from both the
interviews and the DNA specimens will
be used to study independent genetic
and environmental factors as well as
gene-environment interactions for a
broad range of carefully classified birth
defects.
There are no costs to the respondents
other than their time. The total
estimated annualized burden is 5,400
hours.
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Respondents
NBDPS case/control interview .....................................................................................................
Biologic Specimen Collection ......................................................................................................
Dated: November 13, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–27618 Filed 11–19–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–09–09AE]
rwilkins on PROD1PC63 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
VerDate Aug<31>2005
18:26 Nov 19, 2008
Jkt 217001
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Chagas Disease knowledge, attitude,
practices (KAP) study of physicians—
New—Coordinating Center for
Infectious Disease (CCID), National
Center for Zoonotic, Vector-borne, and
Enteric Diseases (NCZVED), Division of
Parasitic Diseases (DPD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Parasitic Diseases is
proposing a knowledge, attitudes, and
practices (KAP) study to determine the
level of physician awareness and
understanding of Chagas disease.
Chagas disease is a blood-borne
parasitic disease, found only in the
Americas, and spread through contact
with the triatomine bug. Chagas disease
can also be contracted through blood
transfusion, organ transplantation, and
from mother to child congenitally. This
disease is not spread through person-toperson contact. Chagas disease can
cause serious heart and stomach illness;
for some patients, treatment with
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
3,600
10,800
1
1
Avg. burden
per response
(In hours)
1
10/60
antiparasitic medications prevents these
serious complications and may
eliminate the infection. The hypothesis
of this research study is that there will
be a dramatic Chagas disease knowledge
deficit among physicians. In the first 20
months of blood donor screening for
Chagas disease, at least 624 positive
blood donors were identified. Currently,
only about 10% of blood donors with
Chagas disease are receiving treatment
medication. It is suspected that most
physicians are not familiar with this
disease and this may negatively impact
patient care: (1) When positive blood
donors see their healthcare provider, (2)
when organs and tissues are
transplanted unknowingly from infected
donors, and (3) when infected mothers
give birth to babies without screening
for Chagas disease. This KAP study will
survey physicians in areas where there
may be more patients with Chagas
disease. The survey will be sent to all
physician members of several partner
organizations. Results will be analyzed
in order to develop physician education
material. That material will then be sent
to all members. Subsequently, a second
follow-up survey, very similar to the
initial one, will be sent in order to
determine levels of knowledge change.
The data collected by this study will
allow DPD to understand, and
consequently develop and appropriately
target medical educational material to
address, Chagas disease knowledge
deficits of physicians.
There is no cost to respondents other
than their time.
E:\FR\FM\20NON1.SGM
20NON1
Agencies
[Federal Register Volume 73, Number 225 (Thursday, November 20, 2008)]
[Notices]
[Pages 70354-70355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27618]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-08-0010]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
The National Birth Defects Prevention Study (NBDPS)--Revision--
National Center on Birth Defects and Developmental Disabilities
(NCBDDD), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Address the following criteria provided in 5 CFR 1320.5(a): CDC has
been monitoring the occurrence of serious birth defects and genetic
diseases in Atlanta since 1967 through the Metropolitan Atlanta
Congenital Defects Program (MACDP). The MACDP is a population-based
surveillance system for birth defects in the 5 counties of Metropolitan
Atlanta, which is being requested for OMB clearance for three
additional years. Its primary purpose is to describe the spatial and
temporal patterns of birth defects occurrence and serves as an early
warning system for new Teratogens. In 1997, the Birth Defects Risk
Factor Surveillance (BDRFS) study, a case-control study of risk factors
for selected birth defects, became the National Birth Defects
Prevention Study (NBDPS). The major components of the study did not
change.
The NBDPS is a case-control study of major birth defects that
includes cases identified from existing birth defect surveillance
registries in nine states,
[[Page 70355]]
including metropolitan Atlanta. Control infants are randomly selected
from birth certificates or birth hospital records. Mothers of case and
control infants are interviewed using a computer-assisted telephone
interview. The interview is estimated to take one hour. A maximum of
thirty-six hundred interviews are planned, 2,700 cases and 900
controls, resulting in a maximum interview burden of 3,600 hours for
all Centers.
Parents are also asked to collect cheek cells from themselves and
their infants for DNA testing. The collection of cheek cells by the
mother, father, and infant is estimated to take about 10 minutes per
person. Each person will be asked to rub 1 brush inside the left cheek
and 1 brush inside the right cheek for a total of 2 brushes per person.
Collection of the cheek cells takes approximately 1-2 minutes, but the
estimate of burden is 10 minutes to account for reading and
understanding the consent form and specimen collection instructions and
mailing back the completed kits. The anticipated maximum burden for
collection of the cheek cells is 1,800 hours.
Information gathered from both the interviews and the DNA specimens
will be used to study independent genetic and environmental factors as
well as gene-environment interactions for a broad range of carefully
classified birth defects.
There are no costs to the respondents other than their time. The
total estimated annualized burden is 5,400 hours.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Respondents Number of responses per per response
respondents respondent (In hours)
----------------------------------------------------------------------------------------------------------------
NBDPS case/control interview.................................... 3,600 1 1
Biologic Specimen Collection.................................... 10,800 1 10/60
----------------------------------------------------------------------------------------------------------------
Dated: November 13, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-27618 Filed 11-19-08; 8:45 am]
BILLING CODE 4163-18-P